NATCO completes acquisition of Dash Pharmaceuticals LLC01 January 2022

Saturday January 1, 2022 at 6:24 pm

NATCO Pharma Inc. USA, a wholly owned subsidiary of NATCO Pharma Limited (NSE: NATCOPHARM; BSE: 524816) (“NATCO”), has completed the acquisition of Dash Pharmaceuticals LLC (“Dash”), a New Jersey based entity. Pursuant to this, Dash will become a 100% wholly owned subsidiary of NATCO Pharma Inc. and a step-down subsidiary of NATCO. The acquisition amount paid is US$ 18 million.

Dash is a front-end pharmaceutical sales, marketing and distribution entity in the USA which is expected to have Net Sales of approximately USD 15 million for the financial year ending December 2021.

This acquisition provides NATCO with a platform to engage with its customers directly in the USA which is the largest pharmaceutical market in the world

Releted Blog

Posted on 19 Nov, 2024
What are the Potential Side Effects of Drinking Jeera and Methi Water?

Do you know that excess Jeera (Cumin) or methi (Fenugreek) water can pose side effects? It is hard to believe that these culinary herbs can also have ...
Posted on 18 Nov, 2024
What are the Sexual Health Benefits of Fenugreek for Females?

Are you aware of the mystical benefits of Fenugreek for females? Fenugreek, known as 'Methi,' is a superfood for women as it supports lactating women,...
Posted on 15 Nov, 2024
What is a Healthy 3000 Calorie Diet Plan?

Are you gearing up for a 3000-calorie daily meal plan? Whether you are targeting increased muscle mass, weight gain, or a stronger physique, the right...

NATCO completes acquisition of Dash Pharmaceuticals LLC01 January 2022

Releted Blog

What are the Potential Side Effects of Drinking Jeera and Methi Water?

What are the Sexual Health Benefits of Fenugreek for Females?

What is a Healthy 3000 Calorie Diet Plan?

Latest Blog

Advertisement

Newsletter Subscription

Advertisement